Chimerix Stock Performance
| CMRX Stock | USD 8.50 0.02 0.23% |
Chimerix holds a performance score of 14 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.91, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chimerix will likely underperform. Use Chimerix sortino ratio, as well as the relationship between the semi variance and rate of daily change , to analyze future returns on Chimerix.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chimerix are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Chimerix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
Five Day Return (0.12) | Year To Date Return 150.74 | Ten Year Return (77.45) | All Time Return (54.76) |
1 | Acquisition by Middleton Fred A of 60000 shares of Chimerix at 1. subject to Rule 16b-3 | 01/16/2025 |
2 | Disposition of 2350 shares by Andriole Michael T. of Chimerix at 4.1005 subject to Rule 16b-3 | 01/30/2025 |
3 | CMRX Stock Skyrockets in 3 Months Heres What You Should Know | 01/31/2025 |
4 | Disposition of 2260 shares by Michelle LaSpaluto of Chimerix at 4.5113 subject to Rule 16b-3 | 02/13/2025 |
5 | Acquisition by Jakeman David of 10855 shares of Chimerix subject to Rule 16b-3 | 02/26/2025 |
6 | North Carolina drugmaker acquired in 935M deal | 03/05/2025 |
7 | Chimerix Shares Gap Up Still a Buy | 03/07/2025 |
8 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates BRDG, CMRX, WBA on Behalf of Shareholders | 03/11/2025 |
9 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of ... | 03/12/2025 |
10 | Disposition of 3610 shares by Jakeman David of Chimerix at 0.9927 subject to Rule 16b-3 | 03/13/2025 |
11 | Herpes Simplex Virus Infections Strategic Analysis Report 2025 Global Market to Reach 6.6 Billion by 2030 - Long-Term Protective Vaccines and Genetic and Molecu... | 03/14/2025 |
12 | Acquisition by Demski Martha J of 18000 shares of Chimerix at 1.11 subject to Rule 16b-3 | 03/17/2025 |
13 | Chimerix Q4 Earnings Snapshot | 03/21/2025 |
14 | Chimerix Inc. Amazing Performance So Far In 2025 | 03/26/2025 |
15 | LTRN 2024 Financial Results | 03/28/2025 |
| Begin Period Cash Flow | 27.7 M |
Chimerix |
Chimerix Relative Risk vs. Return Landscape
If you would invest 348.00 in Chimerix on December 31, 2024 and sell it today you would earn a total of 502.00 from holding Chimerix or generate 144.25% return on investment over 90 days. Chimerix is currently generating 1.8078% in daily expected returns and assumes 9.6243% risk (volatility on return distribution) over the 90 days horizon. In different words, 85% of stocks are less volatile than Chimerix, and 64% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Chimerix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chimerix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chimerix, and traders can use it to determine the average amount a Chimerix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1878
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CMRX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.62 actual daily | 85 85% of assets are less volatile |
Expected Return
| 1.81 actual daily | 36 64% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Chimerix is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chimerix by adding it to a well-diversified portfolio.
Chimerix Fundamentals Growth
Chimerix Stock prices reflect investors' perceptions of the future prospects and financial health of Chimerix, and Chimerix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chimerix Stock performance.
| Return On Equity | -0.56 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (430.74) % | ||||
| Current Valuation | 666.15 M | ||||
| Shares Outstanding | 93.8 M | ||||
| Price To Earning | (3.43) X | ||||
| Price To Book | 6.55 X | ||||
| Price To Sales | 3,761 X | ||||
| Revenue | 212 K | ||||
| Gross Profit | (74.36 M) | ||||
| EBITDA | (96.57 M) | ||||
| Net Income | (88.39 M) | ||||
| Cash And Equivalents | 42.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 458 K | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 2.18 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (74.98 M) | ||||
| Earnings Per Share | (0.99) X | ||||
| Market Capitalization | 797.33 M | ||||
| Total Asset | 146.01 M | ||||
| Retained Earnings | (883.91 M) | ||||
| Working Capital | 112.08 M | ||||
| Current Asset | 228.84 M | ||||
| Current Liabilities | 20.18 M | ||||
About Chimerix Performance
Evaluating Chimerix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Chimerix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chimerix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.9 K | 2 K | |
| Return On Tangible Assets | (0.61) | (0.64) | |
| Return On Capital Employed | (0.79) | (0.83) | |
| Return On Assets | (0.61) | (0.64) | |
| Return On Equity | (0.73) | (0.76) |
Things to note about Chimerix performance evaluation
Checking the ongoing alerts about Chimerix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chimerix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chimerix is way too risky over 90 days horizon | |
| Chimerix appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 212 K. Net Loss for the year was (88.39 M) with loss before overhead, payroll, taxes, and interest of (74.36 M). | |
| Chimerix currently holds about 42.79 M in cash with (74.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Chimerix has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: LTRN 2024 Financial Results |
- Analyzing Chimerix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chimerix's stock is overvalued or undervalued compared to its peers.
- Examining Chimerix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chimerix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chimerix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chimerix's stock. These opinions can provide insight into Chimerix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.